Chiasma, Inc. (CHMA): Price and Financial Metrics
CHMA Price/Volume Stats
Current price | $3.76 | 52-week high | $5.74 |
Prev. close | $4.00 | 52-week low | $2.77 |
Day low | $3.76 | Volume | 8,196,700 |
Day high | $4.10 | Avg. volume | 2,123,740 |
50-day MA | $4.29 | Dividend yield | N/A |
200-day MA | $3.96 | Market Cap | 217.68M |
CHMA Stock Price Chart Interactive Chart >
Chiasma, Inc. (CHMA) Company Bio
Chiasma Inc. focuses on developing and commercializing oral forms of therapies for patients suffering from orphan diseases. The company was founded in 2001 and is based in Newton, Massachusetts.
Latest CHMA News From Around the Web
Below are the latest news stories about Chiasma Inc that investors may wish to consider to help them evaluate CHMA as an investment opportunity.
When Will Chiasma, Inc. (NASDAQ:CHMA) Breakeven?Chiasma, Inc. ( NASDAQ:CHMA ) is possibly approaching a major achievement in its business, so we would like to shine... |
Pulmatrix appoints Director Anand VaradanPulmatrix, Inc. (NASDAQ: PULM), a clinical-stage biopharmaceutical company developing innovative inhaled therapies to address serious pulmonary and non-pulmonary disease using its patented iSPERSE™ technology, today announced the appointment of Anand Varadan to its Board of Directors, effective July 26, 2021. Mr. Varadan brings expertise in commercialization and successful product launches. In addition, Mark Iwicki stepped down from his role on the Board of Directors effective July 23, 2021. |
SHAREHOLDER ALERT: Halper Sadeh LLP Investigates RAVN, BOCH, ONEM, CHMA; Shareholders are Encouraged to Contact the FirmNEW YORK, July 24, 2021 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Raven Industries, Inc. (NASDAQ: RAVN) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to CNH Industrial N.V. for $58.00 per share. If you are a Raven shareholder, click here to learn more about your rights and options. Bank of Commerce Holdings (NASDAQ: BOCH) concerning poten |
SHAREHOLDER ALERT: WeissLaw LLP Reminds ONEM, BOCH, CHMA, and QTS Shareholders About Its Ongoing InvestigationsIf you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this notice or your rights or interests, please contact: |
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates WRI, WBT, CHMA, XOG, USCR, ONEM; Shareholders are Encouraged to Contact the FirmHalper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: |
CHMA Price Returns
1-mo | N/A |
3-mo | N/A |
6-mo | N/A |
1-year | N/A |
3-year | -25.84% |
5-year | 13.94% |
YTD | N/A |
2022 | N/A |
2021 | 0.00% |
2020 | -12.30% |
2019 | 59.49% |
2018 | 82.94% |
Loading social stream, please wait...